CRWENewswire.com is pleased to announce a stock highlight on Exide Technologies (Nasdaq:XIDE), CROCS Inc. (CROX), deCODE genetics Inc. (DCGN) Sign up to receive FREE Stock-PR alerts from CRWENewswire.com at http://www.crwenewswire.com/?p=2546

Exide Technologies Awarded Federal Grant

Exide Technologies was awarded $34.3 million for its proposal for the domestic manufacture of affordable lead-acid batteries incorporating advanced carbon technology.

Exide Technologies (Nasdaq:XIDE) (www.exide.com) is a global leader in stored electrical-energy solutions for both transportation and industrial applications.

CROCS Inc. (CROX) Crocs, Inc. and its subsidiaries design, develop, and manufacture consumer products from specialty resins worldwide. It primarily offers footwear for men, women, and children under the Crocs brand. Web Site: http://www.crocs.com

Recent News: Shares of footwear company Crocs (CROX: 5.72, 1.45, 33.96%) surged more than 30% to 52-week highs on Friday after the company’s second-quarter results topped estimates handily and it said it will make money next year.

deCODE genetics Inc. (DCGN) deCODE genetics, Inc., a

...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Actuate Corp (ACTU) Allied World Assurance Holdings Ltd (AWH) American Italian Pasta Co (AIPC) American Safety Insurance Holdings Ltd (ASI) American Technology Corp (ATCO) Anaren Inc (ANEN) ARCA biopharma Inc (ABIO) Big Lots Inc (BIG) Bionovo Inc (BNVI) BJ's Restaurants Inc (BJRI) Blackrock Kelso Capital Corp (BKCC) Calamos Asset Management Inc (CLMS) Cardtronics Inc (CATM) Credit Suisse Group AG (CS) deCODE genetics Inc (DCGN) Domino's Pizza Inc (DPZ) First Mariner Bancorp (FMAR) General Cable Corp (BGC) HopFed Bancorp Inc (HFBC) Integrys Energy Group Inc (TEG) Kforce Inc (KFRC) Klabin SA (KLBAY) Lancaster Colony Corp (LANC) Linktone Ltd (LTON) MDC Partners Inc (MDCA) Mindspeed Technologies Inc (MSPD) Monarch Casino & ...

For Immediate Release

Chicago, IL - April 27, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Lockheed Martin Corp (LMT), Schlumberger, Ltd. (SLB), Halliburton's (HAL), deCODE genetics, Inc. (DCGN) and Celera Corp. (CRA).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.

Here are highlights from Friday's Analyst Blog:

Lockheed Beats & Ups Guidance

Lockheed Martin Corp (LMT) reported a 1st quarter 2009 profit of $666 million, down 9% from $730 million in the 1st quarter of 2008.

On a per-share basis, the reported result was $1.68 per diluted share, down 4% from $1.75 per diluted share

...

 Yesterday (Thursday), deCODE genetics, Inc. (DCGN) announced that the company signed an agreement with Celera Corp. (CRA). Pursuant to the agreement, deCODE granted Celera non-exclusive worldwide licenses to deCODE's genetic markers for increased risk of major cardiovascular and metabolic diseases, including heart attack, stroke, atrial fibrillation (AF) and type II diabetes. These markers can be incorporated into laboratory tests for assessing and managing individual risk of these diseases.The deCODE markers include single letter variations in the human genome (SNPs) on chromosome 9p21 linked to increased risk of heart attack and aortic aneurysm, SNPs on chromosome 4q25 conferring risk of AF and stroke, and SNPs in the TCF7L2 gene linked to increased risk of type II diabetes. Studies by deCODE and independent academic groups have demonstrated the utility of testing for these markers to better understand individual risk and to inform more effective and personalized prevention ...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Amtrust Financial Services Inc (AFSI) AP Pharma Inc (APPA) Becton Dickinson and Co (BDX) Calavo Growers Inc (CVGW) Cytori Therapeutics Inc (CYTX) Dassault Systemes SA (DASTY) Decode Genetics Inc (DCGN) Dillard's Inc (DDS) Endologix Inc (ELGX) Haemonetics Corp (HAE) Ivanhoe Mines Ltd (IVN) Linktone Ltd (LTON) Navisite Inc (NAVI) Nile Therapeutics Inc (NLTX) Novavax Inc (NVAX) NSTAR (NST) Orchids Paper Products Co (TIS) Papa John's Int'l Inc (PZZA) Provident Energy Trust (PVX) Stericycle Inc (SRCL) TAM SA (TAM) Tucows Inc (TCX) Winner Medical Group Inc (WMDG) View the entire Zacks #1 Rank List.

Zacks Investment Research

Here are the stocks added to the Zacks #1 Rank (”strong buy”) List today:

ACE Ltd (ACE)
The Advisory Board Co (ABCO)
Alliance Imaging Inc (AIQ)
Allied World Assurance Holdings Ltd (AWH)
American Tower Corp (AMT)
Arena Pharmaceuticals Inc (ARNA)
Ariad Pharmaceuticals Inc (ARIA)
Beneficial Mutual Bancorp Inc (BNCL)
CapLease Inc (LSE)
Chinacast Education Corp (CAST)
Choice Hotels International Inc (CHH)
Corinthian Colleges Inc (COCO)
CTI Industries Corp (CTIB)
Daimler AG (DAI)
deCODE genetics Inc (DCGN)
DeVry Inc (DV)
Diageo plc (DEO)
Dollar Tree Inc (DLTR)
Energy Recovery Inc (ERII)
Foster’s Group Ltd (FBRWY)
Huron Consulting Group (HURN)
Imperial Oil Ltd (IMO)
INX Inc (INXI)
J&J Snack Foods Corp (JJSF)
Jazz Pharmaceuticals Inc (JAZZ)
Knight Capital Group Inc (NITE)
Kraft Foods Inc (…

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

The Advisory Board Co (ABCO) Koninklijke Ahold NV (AHONY) Alliance Imaging Inc (AIQ) Amerisafe Inc (AMSF) Arena Pharmaceuticals Inc (ARNA) Ariad Pharmaceuticals Inc (ARIA) AspenBio Pharma Inc (APPY) AstraZeneca plc (AZN) BASF SE (BASFY) CBIZ Inc (CBZ) Chemed Corp (CHE) Church & Dwight Co Inc (CHD) CombinatoRx Inc (CRXX) Continucare Corp (CNU) deCODE genetics Inc (DCGN) EZCORP Inc (EZPW) Hellenic Telecom Organization SA (OTE) Horsehead Holding Corp (ZINC) Human Genome Sciences (HGSI) Jackson Hewitt Tax Service Inc (JTX) Jazz Pharmaceuticals Inc (JAZZ) Kirkland's Inc (KIRK) La Jolla Pharmaceutical Co (LJPC) MAKO Surgical Corp (MAKO) Mitsubishi UFJ Financial Group Inc (MTU) NovaMed Inc (NOVA) Pactiv Corp (PTV) Reed's Inc ...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

The Advisory Board Co (ABCO) Alliance Imaging Inc (AIQ) Allscripts-Misys Healthcare Solutions (MDRX) Almost Family Inc (AFAM) Alnylam Pharmaceuticals Inc (ALNY) Array BioPharma Inc (ARRY) AsiaInfo Holdings Inc (ASIA) athenahealth Inc (ATHN) BearingPoint Inc (BGPT) Chemed Corp (CHE) Coca-Cola Amatil Ltd (CCLAY) Corinthian Colleges Inc (COCO) Corrections Corporation of America (CXW) Cox Radio Inc (CXR) Crown Castle International Corp (CCI) CSG Systems International Inc (CSGS) deCODE genetics Inc (DCGN) Delhaize Group (DEG) Diageo plc (DEO) DRI Corp (TBUS) El Paso Pipeline Partners LP (EPB) Elbit Systems Ltd (ESLT) The Ensign Group Inc (ENSG) EnteroMedics Inc (ETRM) EZCORP Inc (EZPW) FGX International Holdings Ltd (FGXI) Force Protection Inc (FRPT) ...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

AAR Corp (AIR) The Advisory Board Co (ABCO) Alliance Imaging Inc (AIQ) Allscripts-Misys Healthcare Solutions (MDRX) Array BioPharma Inc (ARRY) AsiaInfo Holdings Inc (ASIA) athenahealth Inc (ATHN) BearingPoint Inc (BGPT) Boston Properties Inc (BXP) Chemed Corp (CHE) Coca-Cola Amatil Ltd (CCLAY) Corinthian Colleges Inc (COCO) Corrections Corporation of America (CXW) Cox Radio Inc (CXR) Crown Castle International Corp (CCI) CSG Systems International Inc (CSGS) deCODE genetics Inc (DCGN) Delhaize Group (DEG) DRI Corp (TBUS) El Paso Pipeline Partners LP (EPB) Elbit Systems Ltd (ESLT) The Ensign Group Inc (ENSG) EnteroMedics Inc (ETRM) FGX International Holdings Ltd (FGXI) Force Protection Inc (FRPT) FPIC Insurance Group Inc (FPIC) Gentiva Health Services ...

deCODE genetics, Inc. (DCGN) is a biopharmaceutical company that uses genetics to develop drugs, diagnostics, and pharmacogenetics for the healthcare industry.

3Q08 revenue of $12 million was less than our estimate of $16 million. As of September 30, 2008, the company had $17.7 million in deferred revenue that will be recognized over future reporting periods. The period-on-period increase in revenue for the third quarter was driven principally by growth in the company's genomic services business, which includes the company's diagnostics, deCODEme(TM) personal genome analysis, and contract genotyping businesses.

Operating loss for the third quarter 2008 was $11.3 million, compared to $22.2 million for the third quarter 2007. Net loss for the quarter ending September 30, 2008 was $17.9 million, compared to $24.2 million for the third quarter 2007. In addition to operating loss, net loss figures for the periods presented include interest expense and, in the 2008 periods, unrealized loss resulting

...